Sympathetic overactivity as a cause of hypertension in chronic renal failure.
about
Perspectives on systems biology applications in diabetic kidney diseaseHigh blood pressure in dialysis patients: cause, pathophysiology, influence on morbidity, mortality and managementBlood pressure control in type II diabetics with diabetic retinopathy.Successful treatment with tolvaptan to control blood volume and hyponatremia in a chronic kidney disease patient.Broken Heart Syndrome in a Patient on Maintenance HemodialysisSympathetic activation and baroreflex function during intradialytic hypertensive episodes.Renal sympathetic denervation in the treatment of resistant hypertension.Hypertension in chronic kidney disease: navigating the evidence.Hypertension and the vascular patient.AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease.Angiotensin II receptor blockers in older patients.Salivary Alterations in Rats with Experimental Chronic Kidney Disease.Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.Prenatal programming of hypertension induces sympathetic overactivity in response to physical stressIncreased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease.Quantifying perivascular sympathetic innervation: regional differences in male C57BL/6 mice at 3 and 20 monthsDiabetes mellitus suppresses hemodialysis-induced increases in tear fluid secretion.Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?Nondrug interventions for treatment of hypertension.Sympathetic nervous system function and dysfunction in chronic hemodialysis patients.Blood pressure variability assessed by home measurements: a systematic review.Acute changes in home blood pressure after the Great East Japan Earthquake among patients with chronic kidney disease in Fukushima City.Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease.Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.Extracorporeal life support in severe propranolol and verapamil intoxication.Associations between day-by-day variability in blood pressure measured at home and antihypertensive drugs: the J-HOME-Morning study.Revisiting autonomic dysfunction in end-stage renal disease patients.Hypertension in kidney transplantation is associated with an early renal nerve sprouting.
P2860
Q26823206-3C7C9953-D6CE-4A86-BAC1-229C3792B4B6Q26861624-BC9C04BF-8AF8-4176-AC59-BA9A9CD1F24BQ33234679-4D4A1D94-BF2C-4DC0-A6A0-CEBB671C5ED7Q33622094-95FD1D44-5909-4E4D-8C1B-D12171188B87Q33797244-08DADA64-08AC-42E8-9B54-E255325DBF4CQ34281734-8D348B25-A379-4478-B02D-666E367BD467Q34637470-D4CBA8A3-5963-4A4E-B78A-3714827ED8E2Q35071147-806234C6-55DF-45A1-8AF4-4D99FF373CA4Q35738465-D49FE362-2B54-4183-A9F4-9D9DA479E17FQ35837657-4553A356-296A-461E-88F7-C3A0935FD04EQ35843149-F708C97F-5D88-43BC-AF42-F10BC10139D0Q35918454-BB918C16-0DE0-49FE-AD41-530CE765F09CQ36107868-5DC92AB6-41E8-41A9-BE7A-616895E5854EQ36388949-FF264C70-BD06-403F-9C58-2CC3107AF60FQ36475350-C42BA97B-FE0E-4786-959F-F133C06831FAQ36836484-FBD7E7E8-00C7-477F-8CD3-A00EF90AC993Q37387035-2007E163-8A08-4F9D-B445-D7F0EE0862D6Q37580596-C90CF42B-05E2-4CE9-8040-8D2DBA804983Q37616714-CDBD4BDF-7B6B-4651-9728-D9F1B660D96FQ37786447-CEAFB4A4-D440-41F7-8F80-DF0439DB14D1Q37952476-1D78C8EF-DC1C-49D5-9D25-65D1243CE005Q38102731-F1DB0FB7-59CD-41A6-A413-33E4E18E3DB9Q38189603-3EC825AF-C9A4-4BF8-812D-96853FD96AAAQ41972419-3AD19BAC-0CF1-4DF2-99E3-44D311D1765DQ42008092-26B6C200-609F-4E22-92A9-73BA803D4CABQ43143679-6BA15315-A8B6-4D24-BDC1-65D4686166EEQ44976978-69BA142B-B7CE-47EF-8D9C-D431402F8123Q46801144-ADEB913D-C17C-4142-81AF-F2928C418965Q46864190-36FFBB7D-D6CA-4C4D-B27E-820C0DB03E1AQ51341486-1333E97D-D76F-483D-BB51-559EA5FAECE8Q51671053-A990EB3D-73F6-4194-8A96-E05999E596A6Q52870026-A31A6C7C-A887-4D0C-B490-63DD1A8DFAE5
P2860
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@ast
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@en
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@nl
type
label
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@ast
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@en
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@nl
prefLabel
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@ast
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@en
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@nl
P2093
P1476
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
@en
P2093
Meryem Tuncel
Robert A Augustyniak
Robert D Toto
Ronald G Victor
Weiguo Zhang
P356
10.1097/00004872-200201000-00002
P577
2002-01-01T00:00:00Z